Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The following are the specific investigations within the areas of research;

Epidemiology and trends in self-harm

    • Rates and trends in self-harm and socio-demographic and clinical characteristics of self-harm patients:
      • adults 
      • children and adolescents
      • older people


  • Rates and trends in self-harm in ethnic groups including Black (Caribbean and African), South Asian (Indian, Pakistani, Bangladeshi and Sri Lankan), Chinese and White groups
  • Alcohol and drug misuse and self-harm
  • Characteristics of frequent repeaters of self-harm
  • Impact of the recession on self-harm

Clinical management of self-harm

  • Determinants of type of hospital management following self-harm, and the relationship between management and outcome
  • Validation and refinement of a clinical screening tool to identify risk of repetition of self-harm or suicide following a self-harm episode
  • Relationship between psychosocial assessment following self-harm and subsequent repetition of self-harm, in both the short-term and longer term

Outcome of self-harm, including repetition and mortality

  • Risk of suicide following self-harm in gender and age subgroups, and changes over time
  • Risk factors for suicide 
  • Risk of death from non-suicidal causes 
  • Mortality following self-harm in
    • children and adolescents
    • older people
    • people who misuse alcohol and drugs
    • people in current psychiatric contact
    • different ethnic groups
  • Change in use of different methods of self-harm between episodes and relationship to outcome
  • Pharmaco-epidemiology, including drug toxicology and impacts of changes in prescribing legislation and trends.


  • Impact on self-harm of MHRA decision to withdraw co-proxamol
  • Comparison of size of overdoses of paracetamol in England and Ireland in relation to differing pack sizes


  • Relationship between use of specific antidepressants in self-poisoning and prescribing rates
  • Relative toxicity (lethality) of individual antidepressants
  • Trends in self-poisoning with SSRI antidepressants over time and in relation to MHRA warnings


  • Relative toxicity of individual drugs used for self-harm and suicide